Phase II study of TransOral Surgery for local recurrence after radiotherapy for head and neck cancer in Japa

Phase 2

Recruiting

• Conditions: Residual lesion or local recurrence after radiotherapy for head and neck cancer

• Registration Number: JPRN-UMIN000050014
• Lead Sponsor: ational Cancer Center Hospital East

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-11
• Last Update Posted: 17 October 2023
• Study Completion: 2031-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient has two or more multiple cancers of the head and neck region other than the primary lesion at the time of enrollment. 2) Incurable multiple head and neck cancers or double cancers 3) Scheduled to receive chemotherapy (including endocrine therapy, molecular targeted therapy, or immune checkpoint inhibitors) for multiple head and neck cancers or double cancers at the time of enrollment. 4) Women who might be pregnant 5) Participation in the study is precluded by the presence of psychosis or psychiatric symptoms. 6) Active infection (a fever of >=38 degrees and bacterial infection confirmed on imaging studies or bacteriologic examinations) 7) Investigator determines that the patient is ineligible.

Study & Design

• Study Type: Interventional
• Study Design: Not specified